-
hcup-us.ahrq.gov/reports/statbriefs/sb125.pdf
February 01, 2012 - quartile 50.8 1,343.7a
All other quartiles 51.4 1078.9
Patient residence
Large central … $2,200 $630
Cancer of head and neck 33,400 7.5 $19,900 $2,600 $666
Cancer of brain and nervous … location is one of six categories as defined by the National Center for Health Statistics:
– Large Central … Metropolitan: Central counties of metropolitan areas with a population of
1 million or greater
–
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
December 11, 2018 - relationships with family; it is the leading cause of disability and is often
refractory to treatment.2,3 Nervous … distinct disease entity.1 This multifaceted disease is influenced by
multiple factors (e.g., genetic, central … nervous system, psychological, and environmental
factors), with complex interactions, making assessment … age, sex, presence of comorbidities
(e.g., emotional or mood disorders) or degree of nociplasticity/central … report.
11
Literature Databases: Ovid® MEDLINE®, Cochrane Central
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_A.PDF
January 01, 2004 - SYSTEM 358 0.04
50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 375 0.05
51: VIRAL … SYSTEM NEOPLASMS W/O CC 277 0.03
101: NERVOUS SYSTEM NEOPLASMS W CC 772 0.10
102: NERVOUS SYSTEM NEOPLASMS … SYSTEM W/O CC 737 0.09
341: OTHER DISORDERS OF NERVOUS SYSTEM W CC 837 0.10
342: OTHER DISORDERS OF … NERVOUS SYSTEM W MCC 208 0.03
370: ORBITAL PROCEDURES W/O CC 73 0.01
371: ORBITAL PROCEDURES W CC … Retardation 11 0.00
NEU16: Multiple Sclerosis 499 0.06
NEU17: Myasthenia Gravis 135 0.02
NEU18: Neoplasm: Central
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2003 - 998 0.13
42: DEGENERATIVE NERVOUS SYSTEM DISORDERS EXC MULT SCLEROSIS 1863 0.23
43: MULTIPLE SCLEROSIS … SYSTEM 330 0.04
50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 395 0.05
51: VIRAL … SYSTEM NEOPLASMS W/O CC 274 0.03
101: NERVOUS SYSTEM NEOPLASMS W CC 737 0.09
102: NERVOUS SYSTEM NEOPLASMS … NERVOUS SYSTEM W MCC 160 0.02
370: ORBITAL PROCEDURES W/O CC 51 0.01
371: ORBITAL PROCEDURES W CC … DS_DX_CATEGORY1 14:47 Friday, June 3, 2005
DS_DX_Category1 Frequency
Percent
of
Total
NEU18: Neoplasm: Central
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_SEVERITY.PDF
January 01, 2002 - SYSTEM & RELATED PROCEDURES 5802 0.07
40: SPINAL DISORDERS & INJURIES 1693 0.02
41: NERVOUS SYSTEM … SYSTEM 3053 0.04
50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 3612 0.05
51: … SYSTEM NEOPLASMS W/O CC 2990 0.04
101: NERVOUS SYSTEM NEOPLASMS W CC 7188 0.09
102: NERVOUS SYSTEM … SYSTEM W/O CC 6361 0.08
341: OTHER DISORDERS OF NERVOUS SYSTEM W CC 6854 0.09
342: OTHER DISORDERS … 93 0.00
NEU16: Multiple Sclerosis 4600 0.06
NEU17: Myasthenia Gravis 1185 0.02
NEU18: Neoplasm: Central
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2002 - 981 0.12
42: DEGENERATIVE NERVOUS SYSTEM DISORDERS EXC MULT SCLEROSIS 1784 0.23
43: MULTIPLE SCLEROSIS … SYSTEM 322 0.04
50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 360 0.05
51: VIRAL … SYSTEM NEOPLASMS W/O CC 318 0.04
101: NERVOUS SYSTEM NEOPLASMS W CC 699 0.09
102: NERVOUS SYSTEM NEOPLASMS … NERVOUS SYSTEM W MCC 178 0.02
370: ORBITAL PROCEDURES W/O CC 61 0.01
371: ORBITAL PROCEDURES W CC … DS_DX_Category1 Frequency
Percent
of
Total
NEU17: Myasthenia Gravis 124 0.02
NEU18: Neoplasm: Central
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_A.PDF
January 01, 2002 - 965 0.12
42: DEGENERATIVE NERVOUS SYSTEM DISORDERS EXC MULT SCLEROSIS 1729 0.22
43: MULTIPLE SCLEROSIS … SYSTEM 316 0.04
50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 374 0.05
51: VIRAL … SYSTEM NEOPLASMS W/O CC 306 0.04
101: NERVOUS SYSTEM NEOPLASMS W CC 702 0.09
102: NERVOUS SYSTEM NEOPLASMS … NERVOUS SYSTEM W MCC 169 0.02
370: ORBITAL PROCEDURES W/O CC 57 0.01
371: ORBITAL PROCEDURES W CC … 10 **.**
NEU16: Multiple Sclerosis 484 0.06
NEU17: Myasthenia Gravis 126 0.02
NEU18: Neoplasm: Central
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2004 - SYSTEM 332 0.04
50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 388 0.05
51: VIRAL … SYSTEM NEOPLASMS W/O CC 295 0.04
101: NERVOUS SYSTEM NEOPLASMS W CC 773 0.10
102: NERVOUS SYSTEM NEOPLASMS … SYSTEM W/O CC 722 0.09
341: OTHER DISORDERS OF NERVOUS SYSTEM W CC 820 0.10
342: OTHER DISORDERS OF … NERVOUS SYSTEM W MCC 210 0.03
370: ORBITAL PROCEDURES W/O CC 71 0.01
371: ORBITAL PROCEDURES W CC … = 10 **.**
NEU16: Multiple Sclerosis 525 0.07
NEU17: Myasthenia Gravis 133 0.02
NEU18: Neoplasm: Central
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2003_SummaryStats_SEVERITY.PDF
January 01, 2003 - SYSTEM & RELATED PROCEDURES 3000 0.10
40: SPINAL DISORDERS & INJURIES 573 0.02
41: NERVOUS SYSTEM … SYSTEM 2278 0.08
50: NON-BACTERIAL INFECTIONS OF NERVOUS SYSTEM EXC VIRAL MENINGITIS 2859 0.10
51: … SYSTEM NEOPLASMS W/O CC 505 0.02
101: NERVOUS SYSTEM NEOPLASMS W CC 607 0.02
102: NERVOUS SYSTEM NEOPLASMS … SYSTEM W/O CC 3507 0.12
341: OTHER DISORDERS OF NERVOUS SYSTEM W CC 1944 0.07
342: OTHER DISORDERS … Retardation 67 0.00
NEU16: Multiple Sclerosis 364 0.01
NEU17: Myasthenia Gravis 211 0.01
NEU18: Neoplasm: Central
-
www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chapter5.html
December 01, 2017 - classified as 1) cardiovascular (21.0 percent; e.g., ACE inhibitors, antilipemic agents, beta blockers); 2) central … nervous system (19.0 percent; e.g., antidepressants, non-opioid analgesics); or 3) hormones, synthetics
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2019.pdf
January 01, 2019 - Disorders of The Musculoskeletal
System & Conn Tissue
250,727 8.2
7 1: Diseases & Disorders of The Nervous … 13.84 4.6
34: Cancer of other urinary
organs 1,716 16.14 16.96 5.1
35: Cancer of brain and
nervous … 13.44 1.4
80: Multiple sclerosis 6,730 13.80 14.28 3.4
81: Other hereditary and
degenerative nervous … 29,165 8.27 8.53 3.2
94: Other ear and sense
organ disorders 1,672 13.22 13.64 3.2
95: Other nervous … anomalies 713 15.71 16.69 6.3
215: Genitourinary congenital
anomalies 1,201 16.24 16.57 2.1
216: Nervous
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2018.pdf
January 01, 2018 - System & Conn Tissue
247,955 8.1
7
1: Diseases & Disorders of The Nervous … 13.84 4.6
34: Cancer of other urinary
organs 1,716 16.14 16.96 5.1
35: Cancer of brain and
nervous … 13.44 1.4
80: Multiple sclerosis 6,730 13.80 14.28 3.4
81: Other hereditary and
degenerative nervous … 29,165 8.27 8.53 3.2
94: Other ear and sense
organ disorders 1,672 13.22 13.64 3.2
95: Other nervous … anomalies 713 15.71 16.69 6.3
215: Genitourinary congenital
anomalies 1,201 16.24 16.57 2.1
216: Nervous
-
hcup-us.ahrq.gov/db/nation/nrd/NRDIntroduction2022.pdf
December 01, 2024 - DISEASES AND DISORDERS OF THE
KIDNEY AND URINARY TRACT 255,000 18.0
6 1: DISEASES AND DISORDERS OF THE
NERVOUS … 13.84 4.6
34: Cancer of other urinary
organs 1,716 16.14 16.96 5.1
35: Cancer of brain and
nervous … 13.44 1.4
80: Multiple sclerosis 6,730 13.80 14.28 3.4
81: Other hereditary and
degenerative nervous … 29,165 8.27 8.53 3.2
94: Other ear and sense
organ disorders 1,672 13.22 13.64 3.2
95: Other nervous … anomalies 713 15.71 16.69 6.3
215: Genitourinary congenital
anomalies 1,201 16.24 16.57 2.1
216: Nervous
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
February 01, 2015 - performance improvements in patients with AD.6-9 Intranasal insulin is
delivered directly to the central … nervous system via the olfactory and trigeminal neural pathways,
bypassing the blood-brain barrier … Intranasal delivery
bypasses the blood-brain barrier to target
therapeutic agents to the central … nervous system
and treat neurodegenerative disease.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-nonpregnant-adults-and-adolescents-june-2016
June 07, 2016 - Syphilis infection of the central nervous system (neurosyphilis) can occur at any stage of disease and … Syphilis infection of the nervous system (neurosyphilis) can occur at any stage.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - nervous system; GM1 = monosialotetrahexosylganglioside; HSCT = hematopoietic stem-
cell transplantation … nervous system embryonal tumors, and germ cell tumors. … • For single HSCT versus conventional therapy for central nervous system embryonal
tumors, high-risk … NERVOUS SYSTEM
TUMORS
Sands SA, Oberg JA,
Gardner SL, Whiteley
J. … HIGH RISK CNS
TUMORS
Stem Cell Transplant
for High Risk Central
Nervous System
(CNS) Tumors;
-
hcup-us.ahrq.gov/reports/statbriefs/sb242-Pediatric-ED-Visits-2015.pdf
January 01, 2015 - 23.7
3 21.5 21.5 22.0 24.8
4 (highest) 15.3 15.2 18.4 24.9
Patient residence, %
Large central … Other common reasons included nervous system disorders (4.8 million
visits), digestive disorders (3.4 … 0 2,000,000 4,000,000 6,000,000 8,000,000 10,000,000
Respiratory disorders
Injury and poisoning
Nervous … • Large Central Metropolitan: Counties in a metropolitan area with 1 million or more residents … Metropolitan: Counties in a metropolitan area with 1 million or more residents that
do not qualify as large central
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
August 01, 2023 - Congenital malformations of the central nervous system. In: Gleason CA, Juul SE , eds. … Congenital anomalies of the nervous system: neural tube defects.
-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
January 01, 2012 - This drug combination acts on the central nervous
system as an appetite suppressant. … Phentermine is a central norepinephrine-releasing drug
that was approved by FDA in 1959 as an appetite … This drug combination acts on the central nervous system as an appetite suppressant.
1
Phentermine … is a central norepinephrine-releasing drug that was approved by FDA in 1959 as an
appetite suppressant
-
hcup-us.ahrq.gov/reports/natstats/his95/table2c.htm
February 11, 2011 - Acronyms used in Table 2: CNS--central nervous system; GI--gastrointestinal; LOS--length of stay
in